| Pharmacological, mechanistic, and pharmacokinetic assessment of novel melatonin-tamoxifen drug conjugates as breast cancer drugs M Hasan, MA Marzouk, S Adhikari, TD Wright, BP Miller, MD Matossian, ... Molecular Pharmacology 96 (2), 272-296, 2019 | 38 | 2019 |
| Application of simplex lattice design in formulation and development of buoyant matrices of dipyridamole A Saugat Journal of Applied Pharmaceutical Science 2 (12), 107-111, 2012 | 26 | 2012 |
| Elucidation of the orientation of selected drugs with 2-hydroxylpropyl-β-cyclodextrin using 2D-NMR spectroscopy and molecular modeling S Adhikari, S Daftardar, F Fratev, M Rivera, S Sirimulla, K Alexander, ... International Journal of Pharmaceutics 545 (1-2), 357-365, 2018 | 19 | 2018 |
| Formulation and in-vitro characterization of chitosan biodegradable nanoparticles of Zolmitriptan for migraine treatment SK Mandlik, S Adhikari, NS Ranpise Pharmacie Globale 4 (1), 1, 2013 | 4 | 2013 |
| Development of a Semimechanistic Pharmacokinetic-Pharmacodynamic Model Describing Dextroamphetamine Exposure and Striatal Dopamine Response in Rats and Nonhuman Primates … MM van Gaalen, C Schlumbohm, JH Folgering, S Adhikari, ... Journal of Pharmacology and Experimental Therapeutics 369 (1), 107-120, 2019 | 3 | 2019 |
| Development and Optimization of Dextromethorphan HBr-2-Hydroxy Propyl ß-Cyclodextrin Inclusion Complex Based Orally Disintegrating Tablets Using Response Surface Methodology S Adhikari University of Toledo, 2016 | 3 | 2016 |
| Melatonin-tamoxifen hybrid ligands and their effects on breast cancer M Hasan, MA Marzouk, S Adhikari, T Wright, B Miller, B Peckich, ... Cancer Research 78 (13_Supplement), 3915-3915, 2018 | 2 | 2018 |
| Advancing Glioblastoma drug regimen development to support combination therapy through integrated PKPD modeling and simulation-based predictions S Adhikari, HE Shannon, KE Pollok, RE Stratford Cancer Research 79 (13_Supplement), 3884-3884, 2019 | 1 | 2019 |
| Designing Combination Drug Regimens to Improve Glioblastoma Chemotherapy: A Pharmacokinetic Pharmacodynamic Modeling Approach S Adhikari Purdue University, 2021 | | 2021 |
| Melatonin-tamoxifen drug conjugates: Mechanism against breast cancer cells, and pharmacokinetic assessment in female mice M Hasan, TD Wright, S Adhikari, MA Marzouk, A Pericoloso, K Murgas, ... Cancer Research 79 (13_Supplement), 3893-3893, 2019 | | 2019 |
| 3552 Advancing Glioblastoma (GBM) drug regimen development to support combination therapy through integrated PKPD modeling and simulation-based predictions S Adhikari, HE Shannon, KE Pollok, RE Stratford Journal of Clinical and Translational Science 3 (s1), 1-2, 2019 | | 2019 |
| Mechanism-Based Pharmacokinetic-Pharmacodynamic Model Describing Dextroamphetamine Exposure and Striatal Dopamine Response in Rats and Non-Human Primates following a Single … M van Gaalen, C Schlumbohm, J Folgering, S Adhikari, C Bhattacharya, ... Journal of Pharmacology and Experimental Therapeutics, 2019 | | 2019 |
| FORMULATION AND in-vitro CHARACTERIZATION OF CHITOSAN BIODEGRADABLE NANOPARTICLES OF... S Adhikari, SK Mandlik, N Ranpise | | |
Robert StratfordAdjunct Associate Professor, Indiana University School of MedicineVerified email at iu.edu
